Hence, in addition to its detrimental effect in MS lesions, a second local wave of MMP7 activity may be beneficiary by aiding remyelination by clearing OPC maturation‐inhibiting ECM molecules and degrading MBP in myelin debris. This evidence concerns the gene MMP7 and myeloid sarcoma.